Cormorant Asset Management, LP has filed its 13F form on May 15, 2024 for Q1 2024 where it was disclosed a total value porftolio of $1.74 Billion distributed in 57 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Moon Lake Immunotherapeutics with a value of $427M, Eye Point Pharmaceuticals, Inc. with a value of $142M, Arcellx, Inc. with a value of $124M, Alpine Immune Sciences, Inc. with a value of $107M, and Bridge Bio Pharma, Inc. with a value of $99M.
Examining the 13F form we can see an increase of $76.3M in the current position value, from $1.66B to 1.74B.
Cormorant Asset Management, LP is based out at Boston, MA
Below you can find more details about Cormorant Asset Management, LP portfolio as well as his latest detailed transactions.
